Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study

INTRODUCTION: An understanding of real-world predictors of abatacept retention is limited. We analysed retention rates and predictors of abatacept retention in biologic-naïve and biologic-failure patients in a 12-month interim analysis of the 2-yearAbataCepTIn rOutiNe clinical practice (ACTION) stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Mariette, Xavier, Lorenz, Hanns-Martin, Galeazzi, Mauro, Cantagrel, Alain, Nüßlein, Hubert G, Chartier, Melanie, Elbez, Yedid, Rauch, Christiane, Le Bars, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761291/
https://www.ncbi.nlm.nih.gov/pubmed/29435360
http://dx.doi.org/10.1136/rmdopen-2017-000538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761291/
https://www.ncbi.nlm.nih.gov/pubmed/29435360
http://dx.doi.org/10.1136/rmdopen-2017-000538

Ejemplares similares